![Melt van der Spuy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Melt van der Spuy worked as a Managing Director at Eli Lilly Ranbaxy Ltd.
and as a Vice President-Emerging Markets at Elanco Animal Health, Inc. from 2013 to 2015.
Eerdere bekende functies van Melt van der Spuy
Bedrijven | Functie | Einde |
---|---|---|
ELANCO ANIMAL HEALTH INCORPORATED | Corporate Officer/Principal | 01-01-2015 |
Eli Lilly Ranbaxy Ltd.
![]() Eli Lilly Ranbaxy Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Ranbaxy Ltd. is an Indian company that manufactures and sells pharmaceutical products. The company is based in New Delhi, India. The company was founded in 1993. Edgard Olaizola has been the CEO of the company since 2013. Eli Lilly Ranbaxy was acquired by Eli Lilly & Co. from Ranbaxy Laboratories Ltd. on August 08, 2001 for $17 million. | Algemeen Directeur | 01-09-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Eli Lilly Ranbaxy Ltd.
![]() Eli Lilly Ranbaxy Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Ranbaxy Ltd. is an Indian company that manufactures and sells pharmaceutical products. The company is based in New Delhi, India. The company was founded in 1993. Edgard Olaizola has been the CEO of the company since 2013. Eli Lilly Ranbaxy was acquired by Eli Lilly & Co. from Ranbaxy Laboratories Ltd. on August 08, 2001 for $17 million. | Health Technology |